Aristeia Capital’s NuVasive, Inc. NUVA Stock Holding History

Aristeia Capital’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-44,600	Closed	-$2.26M	–	106
2020 Q1	$2.26M	Buy	+44,600	New	+$2.99M	0.19%	49
2016 Q2	–	Sell	-98,600	Closed	-$4.8M	–	55
2016 Q1	$4.8M	Buy	+98,600	New	+$4.47M	0.56%	31

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aristeia Capital's NUVA Position: Q2 2020 in Review

Aristeia Capital sold out of NuVasive, Inc. (NUVA) in Q2 2020, closing a stake of 44,600 shares — an estimated $2.26M sold.

Aristeia Capital first reported a position in NUVA in Q1 2016 and held it in 2 quarters. The position peaked at $4.8M in Q1 2016. 290 funds tracked by Wall St. Rank hold NUVA as of Q2 2020.

Aristeia Capital reported no remaining NuVasive, Inc. position as of Q2 2020 after selling out during the quarter.
Aristeia Capital sold 44,600 NuVasive, Inc. shares in Q2 2020, an estimated $2.26M.
Aristeia Capital first reported a position in NuVasive, Inc. in Q1 2016 and held it in 2 quarters.
Aristeia Capital's NuVasive, Inc. position peaked at $4.8M in Q1 2016.
290 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2020.

Based on Aristeia Capital's 13F filing for Q2 2020, filed 17 Aug 2020.